Advanced BioHealing, Inc. Announces First Diabetes Patient Adherence Program for Foot Ulcer Treatment
11/3/2009 9:44:01 AM
WESTPORT, Conn.--(BUSINESS WIRE)--Advanced BioHealing, Inc. (ABH), a leader in commercializing the promise of regenerative medicine and the maker of Dermagraft®, launched during American Diabetes Month the Heal2gether Partnership Program for diabetes patients and their physicians. Focused on patient adherence, Heal2gether aims to increase awareness and proper care of diabetic foot ulcers (DFUs), enhance the effective use of living cell technologies in treating DFUs, and encourage patients to take an active role in their healing process.
comments powered by